No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL.

Journal of the International AIDS Society
Andrew AtkinsonOpportunistic Infections Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) st

Abstract

Since the beginning of the HIV epidemic in resource-rich countries, Pneumocystis jirovecii pneumonia (PjP) is one of the most frequent opportunistic AIDS-defining infections. The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) has shown that primary Pneumocystis jirovecii Pneumonia (PjP) prophylaxis can be safely withdrawn in patients with CD4 counts of 100 to 200 cells/µL if plasma HIV-RNA is suppressed on combination antiretroviral therapy. Whether this holds true for secondary prophylaxis is not known, and this has proved difficult to determine due to the much lower population at risk. We estimated the incidence of secondary PjP by including patient data collected from 1998 to 2015 from the COHERE cohort collaboration according to time-updated CD4 counts, HIV-RNA and use of PjP prophylaxis in persons >16 years of age. We fitted a Poisson generalized additive model in which the smoothed effect of CD4 was modelled by a restricted cubic spline, and HIV-RNA was stratified as low (<400), medium (400 to 10,000) or high (>10,000copies/mL). There were 373 recurrences of PjP during 74,295 person-years (py) in 10,476 patients. The PjP incidence in the different plasma HIV-RNA strata differed significantly a...Continue Reading

References

Dec 24, 1992·The New England Journal of Medicine·H Masur
Feb 21, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cristina MussiniUNKNOWN Changes in Opportunistic Prophylaxis (CIOP) Study Group
Apr 14, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John EvisonKathrin Mühlemann
Jul 22, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Amanda MocroftHansjakob Furrer
Oct 19, 2013·PLoS Medicine·Amanda MocroftUNKNOWN Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord
Aug 26, 2016·The Journal of Infectious Diseases·Kate BuchaczUNKNOWN North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA
Sep 16, 2016·Journal of the International Association of Providers of AIDS Care·Xia LinJacek Skarbinski
Jul 12, 2017·Journal of the International AIDS Society·Lukas FennerUNKNOWN International Epidemiology Database to Evaluate AIDS in Southern Africa (IeDEA-SA)
Nov 16, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Olivia VeitUNKNOWN Swiss HIV Cohort Study
Jan 10, 2019·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Alison E BrownUNKNOWN The Ecdc Dublin Declaration Monitoring Network
Jun 22, 2019·AIDS·Agnieszka WójtowiczUNKNOWN Swiss HIV Cohort Study
May 26, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andrew AtkinsonUNKNOWN Opportunistic Infections Project Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (CO

❮ Previous
Next ❯

Software Mentioned

R
mgcv
COHERE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.